{
  "filename": "48---A-31-Year-Old-Woman-from-Tanzania-With-Acu_2022_Clinical-Cases-in-Tropi.pdf",
  "markdown_path": "./Processed/markdown/48---A-31-Year-Old-Woman-from-Tanzania-With-Acu_2022_Clinical-Cases-in-Tropi.md",
  "images": [
    {
      "page": 1,
      "path": "./Processed/images/48---A-31-Year-Old-Woman-from-Tanzania-With-Acu_2022_Clinical-Cases-in-Tropi/48---A-31-Year-Old-Woman-from-Tanzania-With-Acu_2022_Clinical-Cases-in-Tropi_p1_img1.jpeg"
    }
  ],
  "table_text": "TABLE 48.1 Flaccid versus Spastic Paraparesis\n| Clinical Presentation | Neuroanatomical Diagnosis | Examples of Common Aetiologies in Tropical Countries |\n| :------------------------------------------------------ | :------------------------ | :--------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| **Flaccid paraparesis**                                 |                           |                                                                                                                                                                  |\n| with bladder involvement and/or sensory level           | Acute spinal cord lesion  | inflammation of the spinal cord (¼ myelitis), ischaemia of the spinal cord (¼ spinal infarction)                                                                 |\n| with bladder involvement and/or sensory level           | Acute cauda equina lesion | metastatic malignancy, schistosomiasis                                                                                                                           |\n| without bladder dysfunction, without sensory level      | Polyradiculoneuropathy    | Guillain-Barr e-syndrome, tuberculous arachnoiditis, CMV in HIV                                                                                                  |\n| without bladder dysfunction, without sensory level      | Polyneuropathy            | Diabetes, HIV-related, nutritional                                                                                                                               |\n| **Spastic paraparesis**                                 |                           |                                                                                                                                                                  |\n|                                                         | Chronic spinal cord lesion | Compression of spinal cord because of Pott´s disease, chronic viral infections such as HTLV-1 and HIV                                                            |\n\nTABLE 48.2 Laboratory Results on Admission\n| Parameter (Unit)                 | Patient    | Normal range |\n| :------------------------------- | :--------- | :----------- |\n| ESR (mm/h)                       | 19         | 10           |\n| Random blood glucose (mmol/l)    | 5.6        | 3.9-11.1     |\n| HIV-Serology and p24 Antigen     | negative   | negative     |\n| VDRL                             | negative   | negative     |\n| Schistosomiasis-serology         | negative   | negative     |\n| Urine for ova of S. haematobium  | negative   | negative     |\n| Stool for ova of S. mansoni      | negative   | negative     |\n\nTABLE 48.3 CSF Results\n| Parameter (Unit)                     | Patient             | Normal range    |\n| :----------------------------------- | :------------------ | :-------------- |\n| CSF white cell count (cells/μl)      | 11 (90% lymphocytes) | 0-5             |\n| CSF protein (g/L)                    | 1.11                | <0.45           |\n| CSF glucose (mmol/l)                 | 3.9                 | 2.8-3.8\\*       |\n| Gram stain                           | negative            | negative        |\n| Ziehl-Neelsen stain                  | negative            | negative        |\n| Xpert MTB/RIF                        | negative            | negative        |\n| VDRL in the CSF                      | negative            | negative        |\n| \\*{1/2} to {2/3} of paired serum glucose sample 133 |                     |                 |\n\nTABLE 48.4 Pathophysiology of Acute Transverse Myelitis\n| Pathophysiology                                                                                                                                                      | Treatment                                                                    |\n| :------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :--------------------------------------------------------------------------- |\n| **Idiopathic, (majority of the cases)** <br> Presumably an autoimmune phenomenon <br> Might be a manifestation of a chronic autoimmune demyelinating CNS disease (such as NMO and multiple sclerosis) | Corticosteroids against inflammation                                         |\n| **Associated with infection** <br> Direct invasion of the spinal cord by microorganisms                                                                              | Causative treatment e.g. acyclovir for VZV myelitis                          |\n| **Autoimmune phenomenon as a result of infection elsewhere (“parainfectious”)** <br> Might be associated with vaccination against the microorganism                     | Corticosteroids against inflammation                                         |\n| **Associated with a systemic autoimmune disorder** <br> Autoimmune phenomenon <br> Often the autoimmune disorder (e.g. lupus or secondary vasculitis) in the patient is already known | Corticosteroids against inflammation                                         |",
  "table_source": "/Users/macintoshhd/Downloads/Project-Dr.Khanh/Clinical-RAG/Processed/out_all_structured/48---A-31-Year-Old-Woman-from-Tanzania-With-Acu_2022_Clinical-Cases-in-Tropi-tables.md",
  "table_label": "TABLE 48.1",
  "table_caption": "Flaccid versus Spastic Paraparesis"
}